IPP Bureau
New spesolimab data show promising results in patients with generalised pustular psoriasis flares
By IPP Bureau - March 28, 2022
Clinical improvements were consistent across patient subgroups including age, gender, ethnicity, and IL-36 gene mutation status
Aurobindo enters domestic formulations space with the acquisition of Veritaz for Rs 171 Cr
By IPP Bureau - March 28, 2022
Veritaz has over 40 brands marketed across the acute and critical care therapeutic segments
ILC Dover launches liquid single-use bioprocessing bags for biotherapeutics market
By IPP Bureau - March 28, 2022
The company’s differentiated value proposition comes during a time of unprecedented disruption in the life science supply chain
Phase 3 data show Dupixent improves signs and symptoms of prurigo nodularis
By IPP Bureau - March 27, 2022
There are currently no approved systemic treatments for prurigo nodularis; regulatory filings for prurigo nodularis planned in the first half of 2022
Aster DM Healthcare signs MoU with Tamil Nadu govt to invest Rs. 500 crore
By IPP Bureau - March 27, 2022
The MoU proposed investments in hospitals, pharmacies and laboratories in the state
NMPA approves Hansizhuang, its first monoclonal antibody
By IPP Bureau - March 27, 2022
It also empowers domestic precision immunotherapy for tumours and promotes the high-quality development of China's biopharmaceutical industry
ScienceMedia and Apex Mobile Clinical Research sign partnership for clinical trial training
By IPP Bureau - March 27, 2022
The implementation of ScienceMedia's solutions will ultimately help AMCR collapse patient recruitment and enrollment
NATHEALTH 8th annual summit in New Delhi from March 28-29.
By IPP Bureau - March 26, 2022
More than 120 speakers and 5,000 delegates are expected to attend
RCSE partner with Rela Hospitals for advanced surgical course
By IPP Bureau - March 26, 2022
These courses are for pre-selected candidates who have completed their MBBS with an additional 2 years of surgical experience training
Confluent Medical Technologies to set up facility in Hyderabad
By IPP Bureau - March 26, 2022
Arizona-based, leading medical devices company, Confluent Medical Technologies, will be establishing a pilot manufacturing facility in Hyderabad.
Novavax to participate in two booster studies using its COVID-19 vaccine
By IPP Bureau - March 26, 2022
U.S. NIAID-sponsored trial will evaluate heterologous booster regimens, including NVX-CoV2373, after primary series with current USFDA approved or emergency use authorized-vaccines
Fujifilm India unveils new range of CT, MRI and ultrasound machines
By IPP Bureau - March 26, 2022
The enhanced portfolio includes the Scenaria View, Supria series, The Echelon Smart and Arietta series
Evusheld recommended for market authorisation in EU
By IPP Bureau - March 25, 2022
Recommendation based on Phase III PROVENT trial showing a significant reduction in the risk of developing symptomatic COVID-19, with protection lasting at least six months
Leadership changes at MedGenome
By IPP Bureau - March 25, 2022
Co–Founder Sam Santhosh steps down as Chairman and Group CEO; will remain on Board of Directors. Co–founder Mahesh Pratapneni appointed Group CEO. Dr. Felix Olale appointed Chairman of the Board
Aquavit Files IND with USFDA for DTX-021, a new botulinum toxin
By IPP Bureau - March 25, 2022
Aquavit will officially unveil the Dermatox and Microtox programs at the Annual American Academy of Dermatology, the world's largest dermatology conference scheduled from March 25-29, 2022, in Boston, MA
